Konsume
Interval Day Week Month
Newswire Search Past 90 Days 348 stories 53 Publishers
Trending Today
Sort By: Snapshot
Buzz
Media Coverage
World View

Related Topics
Topic # Mentions Topic Reach
phase40-
the29-
data29-
biotech24-
study21-
ipo11-
summit10-
develop8-
lilly8-
rna8-
collaboration7-
research7-
next6-
nda6-
medical6-
ind6-
sign5-
pharma5-
positive5-
oncology5-
launches5-
concerns5-
financing4-
center4-
partnership4-
pipeline4-
adc4-
viking4-
startup4-
firm4-
placement3-
capricor3-
runway3-
blood3-
public offering3-
stock rises3-
share3-
theft3-
ivonescimab3-
response3-
shares fall3-
fall3-
strong3-
Prominent Journalists
Byline Articles Written Avg Reach
RTTNews Staff Writer 130 -
By Salong Debbarma 25 -
by PR Newswire 18 -
Frank Vinluan 17 -
Gayathry Prakash 16 -
Prabha Kurup 14 -
TajSabreen Ahamed 10 -
Bob D'Angelo, Cox Media Group National Content Desk 5 -
Adam Feuerstein 4 -
Elaine Chen 3 -
Lori DeBoer 3 -
Tony Jackson 3 -
Jason Mast 3 -
Thomas Hughes 2 -
Murray Ward 2 -
Meghana Keshavan 2 -
By srivani venna 2 -
Lucas High 2 -
Mica Kanner-Mascolo 2 -
Chris Markoch 2 -


Patient CRM Modernization: Four Decisions Technology Can't Make for You

HITC Staff — hitconsultant.net


Aclaris Therapeutics Shares Fall 3% After Announcement Of ATI-052 Study Data, Stock Offering Pricing

RTTNews Staff Writer — rttnews.com


PYC Therapeutics Shares Surge 9.4% as RNA Drug Developer Rebounds After Pullback Following Kidney Disease Data

Tony Jackson — ibtimes.com.au


Lycia Shares Fall Nearly 10% After Hours Following $365.1 Mln IPO Closing

RTTNews Staff Writer — rttnews.com


Buy the Dip: 4 Stocks the Market Marked Down Too Far Ahead of Big Catalysts

Bridget Bennett — marketbeat.com


Can-Fite Presents Final Phase 2a Data For Namodenoson In Pancreatic Cancer

Gayathry Prakash — rttnews.com


Oruka Therapeutics Stock Jumps 12% After Positive Phase 2b Psoriasis Trial

RTTNews Staff Writer — rttnews.com


TransCode Reports Phase 1a Data For TTX-MC138 In Advanced Solid Tumors

RTTNews Staff Writer — rttnews.com


Oruka's Experimental Drug Shows Strong Skin Clearance In Phase 2 Psoriasis Trial

RTTNews Staff Writer — rttnews.com


Lunit And Summit Collaborate On AI-Powered Biomarker Discovery For Ivonescimab

Gayathry Prakash — rttnews.com

Execution: 2.53 Seconds. 31.8 mb used.